VisEn Medical Inc. acquired a 45-patent portfolio and related fluorescent imaging agent platforms from German giant Bayer Schering Pharma AG for an undisclosed amount.

The Bedford, Mass.-based imaging systems maker said it will integrate its newly acquired intellectual property into its own programs. The deal takes VisEn’s portfolio of fluorescent imaging agent patents to more than 150 worldwide.